Edition:
United States

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

23.80USD
1:37pm EDT
Change (% chg)

$-1.15 (-4.61%)
Prev Close
$24.95
Open
$24.74
Day's High
$24.74
Day's Low
$23.61
Volume
25,921
Avg. Vol
104,051
52-wk High
$33.86
52-wk Low
$8.10

Chart for

About

Akcea Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. The Company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense... (more)

Overall

Beta: --
Market Cap(Mil.): $2,135.55
Shares Outstanding(Mil.): 85.59
Dividend: --
Yield (%): --

Financials

  AKCA.OQ Industry Sector
P/E (TTM): -- 29.97 34.18
EPS (TTM): -1.47 -- --
ROI: -76.11 13.65 13.17
ROE: -- 15.43 15.15

BRIEF-Akcea Posts Q4 Loss Per Share $0.35

* AKCEA REPORTS FINANCIAL RESULTS AND HIGHLIGHTS FOR FOURTH QUARTER AND YEAR END 2017

Feb 26 2018

BRIEF-Akcea Completes Enrollment In Phase 2B Study Of Akcea-Apo(A)-LRx

* AKCEA COMPLETES ENROLLMENT IN PHASE 2B STUDY OF AKCEA-APO(A)-LRX Source text for Eikon: Further company coverage:

Feb 07 2018

Earnings vs. Estimates